Benefit of a Short Chain Peptide as a Targeting Ligand of Nanocarriers for a Brain-Driven Purpose
Treatment of glioma remains a critical challenge worldwide, since the therapeutic effect is greatly hindered by poor transportation across the blood brain barrier (BBB) and low penetration into tumor cells. In this study, a peptide-conjugated nano-delivery system was explored for the purpose of glio...
Saved in:
Published in | Pharmaceutics Vol. 13; no. 8; p. 1249 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Basel
MDPI AG
12.08.2021
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!